Statins decrease the risk of decompensation in hepatitis B virus – and hepatitis C virus–related cirrhosis: A population‐based study
Conclusion: Statin use decreases the decompensation rate in both HBV‐ and HCV‐related cirrhosis. Of borderline significance is a decreased decompensation rate in alcohol‐related cirrhosis. (Hepatology 2017).
Source: Hepatology - Category: Internal Medicine Authors: Fu ‐Ming Chang, Yen‐Po Wang, Hui‐Chu Lang, Chia‐Fen Tsai, Ming‐Chih Hou, Fa‐Yauh Lee, Ching‐Liang Lu Tags: Liver Failure, Cirrhosis and Portal Hypertension Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Cholesterol | Cirrhosis | Health Insurance | Hepatitis | Hepatitis B | Hepatitis C | Hepatocellular Carcinoma | Hypertension | Insurance | Internal Medicine | Liver | Liver Cancer | Statin Therapy | Study | Urology & Nephrology